To report the results of a national survey aimed at quantifying the current level of diffusion of Levodopa/carbidopa intestinal gel (LCIG) in Italy.
Sensi, M., Cossu, G., Mancini, F., Pilleri, M., Zibetti, M., Modugno, N., et al. (2017). Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up. PARKINSONISM & RELATED DISORDERS, 38, 90-92 [10.1016/j.parkreldis.2017.02.020].
Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up
Pierantozzi M.;Stefani A.;
2017-01-01
Abstract
To report the results of a national survey aimed at quantifying the current level of diffusion of Levodopa/carbidopa intestinal gel (LCIG) in Italy.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
sensi 2017.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
220.56 kB
Formato
Adobe PDF
|
220.56 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
